Marvel Studios is reportedly prioritising Spider-Man 5, Black Panther 3, Shang-Chi 2, an X-Men project, and a Thunderbolts sequel as its next wave of films, according to The Times of India and industry insider reports. Doctor Strange 3 has been pushed to the backburner. The priority order suggests Marvel is doubling down on proven, crowd-pulling franchises after a string of underperforming releases.
The 5W+H: Who, What, When, Where, Why, How
- Who: Marvel Studios, under the stewardship of Kevin Feige, is reshaping its post-Secret Wars development slate.
- What: The studio has reportedly designated Spider-Man 5, Black Panther 3, Shang-Chi 2, X-Men, and a Thunderbolts sequel as top-priority projects, while Doctor Strange 3 is currently deprioritised, according to The Times of India and insider Alex Perez's reports.
- When: The priority list has emerged in 2026, reportedly following the releases of Avengers: Doomsday and Secret Wars, as the studio charts its next multi-year phase.
- Where: Marvel Studios headquarters in Burbank, California, with release strategy implications spanning global markets including India's Hindi belt.
- Why: A series of box-office disappointments and audience fatigue with lesser-known properties appear to have pushed the studio toward franchises with established, bankable fanbases — particularly in price-sensitive international markets like India.
- How: By concentrating development resources on proven IP — Spider-Man's Tom Holland-era global dominance, Black Panther's cultural cachet, Thunderbolts' ensemble spy appeal — and shelving riskier expansions like a third Doctor Strange film, Marvel is reportedly narrowing its funnel to maximise opening-weekend certainty.
Here is a number that should haunt Kevin Feige's whiteboard: of the last six MCU releases before Avengers: Doomsday, not a single one crossed the ₹100-crore mark in India's Hindi belt. Not Eternals-scale ambition, not Ant-Man's comic charm, not the multiverse itself could do what a single Spider-Man trailer accomplishes before breakfast — set the Indian internet on fire. Now, according to a detailed report by The Times of India, Marvel has finally put that knowledge on paper. Spider-Man 5, Black Panther 3, a Thunderbolts sequel, Shang-Chi 2, and an X-Men project sit at the top of the studio's development priorities. Doctor Strange 3? Pushed to the backburner.
The list reads less like a creative roadmap and more like a survival manual. And for Indian audiences — the ones who made Spider-Man: No Way Home a ₹200-crore-plus phenomenon in Hindi alone — the message is unmistakable: Marvel is done experimenting on your ticket money.
View on X
The Priority Ladder — and What It Really Says
Let us lay out the hierarchy as it has emerged from multiple insider accounts, most prominently industry scooper Alex Perez's breakdown cited across trade circles. Spider-Man 5 is reportedly in active development at Marvel Studios. Black Panther 3 and Shang-Chi 2 follow as high-priority sequels. An X-Men project — the franchise Marvel inherited from Fox and has been teasing for years — is also on the fast track. A Thunderbolts sequel rounds out the top tier, riding whatever goodwill the first instalment generates.
View on X
And then there is what is NOT on the list. Doctor Strange 3 is currently on the backburner, as confirmed by multiple fan-tracking accounts citing Perez's intel. The Multiverse Saga's supposed anchor character — the man whose second film literally cracked open the multiverse — is being benched. Think about that for a moment. Marvel spent two phases telling audiences that Doctor Strange was the connective tissue of the entire MCU. Now, the tissue is apparently expendable.
View on X
Inside Talk
The chatter in trade circles is blunt: this is not creative curation — it is triage. Industry insiders speculate that the decision to elevate Spider-Man 5 above all else is driven by one cold, uncomfortable truth: Spider-Man is the only MCU solo franchise that still opens like an event film in every single global market, India included. "The talk in distribution circles," as one analyst familiar with Disney India's strategy reportedly put it, "is that Marvel finally accepts it has a two-tier problem — five franchises that print money and fifteen that need life support."
Fans, predictably, are divided. Some are elated at the focus on proven winners. Others smell retreat. The mood across Indian MCU fan communities is a mix of relief — finally, films they actually want — and quiet anxiety about whether a narrower MCU means a less interesting one.
View on X
(This section reflects industry chatter and unverified speculation, not confirmed fact.)
The India Equation — Why This List Matters More in Mumbai Than Manhattan
Here is the dimension the global coverage misses entirely. In North America, a mid-tier MCU film can limp to $200 million on brand loyalty alone and still turn a profit once Disney+ streaming revenue is factored in. In India, the maths is merciless. A Marvel film either opens as an EVENT — ₹15 crore-plus on Day 1 in Hindi — or it dies in the second week, crushed between a Telugu blockbuster on one screen and a Bollywood family drama on the other. There is no gentle middle ground.
Spider-Man: No Way Home proved the ceiling: ₹218 crore lifetime in Hindi, per trade reports. Black Panther: Wakanda Forever, for all its cultural significance, managed a comparatively modest run. The Marvels barely registered. Ant-Man and the Wasp: Quantumania was a footnote. Indian audiences, particularly in the Hindi belt, have demonstrated with ruthless clarity which MCU heroes they will pay for in theatres and which they will happily wait to stream at home.
Marvel's new priority list, India Herald's read suggests, is the studio finally aligning its production strategy with what Indian (and global emerging-market) audiences have been screaming through their wallets for three years: give us the heroes we love, or we will spend that ₹350 ticket on something else.
Black Panther 3 — Cultural Franchise or Obligation?
The inclusion of Black Panther 3 is arguably the most fascinating entry on the list. Wakanda Forever, released in the shadow of Chadwick Boseman's death, was both a critical success and a commercially complicated one — it earned over $850 million globally, according to Box Office Mojo, but fell short of the first film's $1.35 billion. In India, its performance was respectable but not explosive.
So why prioritise a third instalment? The speculation in industry circles is that Marvel views Black Panther as its most culturally significant franchise outside the Avengers banner — one that carries brand equity beyond pure box-office arithmetic. A well-executed third film, with a new narrative not defined by grief, could recapture the cultural-event energy of 2018. The risk, of course, is that audiences have moved on and that the franchise's emotional peak is permanently behind it.
Thunderbolts — The Quiet Bet That Could Change Everything
A Thunderbolts sequel making the priority list before the first film has even fully settled into the cultural conversation is a tell in itself. It suggests Marvel is confident enough in the anti-hero ensemble format — think Suicide Squad but with a Kevin Feige polish — to commit to a franchise. For India, where ensemble action films (Avengers, Fast & Furious) consistently outperform solo outings, a Thunderbolts series could be the studio's most strategically Indian-market-friendly play.
View on X
What Marvel Is Really Admitting
Strip away the press-release optimism and what you have is an admission that the "everything connects, everything matters" MCU model has hit a wall. Not every corner of the Marvel universe can sustain a $200-million-budget theatrical release. Not every Disney+ series graduate deserves a film. And most critically for Indian distributors and exhibitors — not every MCU logo on a poster guarantees a packed opening weekend anymore.
The priority list is Marvel drawing a circle around the properties it believes can still open big, hold screens, and justify the economics of a global theatrical release in an era where audiences have infinite choices and finite patience. Spider-Man sits inside that circle, unquestioned. Black Panther and Thunderbolts sit inside it with conditions attached. Doctor Strange, for now, sits outside, watching.
The question that should keep Feige's India team up at night is not whether Spider-Man 5 will work — it will. The question is what happens when the circle gets smaller. Because if Marvel's answer to a shrinking audience is to make fewer, safer bets, then the studio that once convinced Indian multiplex audiences to care about a talking raccoon and a sentient tree is now admitting it has forgotten how. And that, for a franchise built on the audacity of the unexpected, might be the most telling priority of all.
By the Numbers
- Spider-Man: No Way Home earned over ₹218 crore lifetime in Hindi in India, per trade reports — making it the highest-grossing MCU solo film in the market by a wide margin.
- Black Panther (2018) earned $1.35 billion globally, according to Box Office Mojo, while Wakanda Forever earned over $850 million — a significant drop that frames the creative challenge facing a third instalment.
- Of the last several MCU releases before Avengers: Doomsday, none crossed the ₹100-crore mark in India's Hindi belt, per trade tracking — underscoring the audience selectivity that appears to be driving Marvel's new priority order.
Key Takeaways
- Marvel Studios has reportedly placed Spider-Man 5, Black Panther 3, Shang-Chi 2, X-Men, and a Thunderbolts sequel at the top of its development priorities, per The Times of India and insider reports — while Doctor Strange 3 has been pushed to the backburner.
- The priority order suggests Marvel is retreating to proven, event-level franchises after several mid-tier MCU releases underperformed globally and particularly in India's price-sensitive Hindi belt.
- Spider-Man remains the only MCU solo franchise that consistently opens as a theatrical event in India, with No Way Home crossing ₹218 crore in Hindi alone — making its sequel the safest bet on the list.
- India Herald's assessment is that this list represents Marvel formally admitting that not every MCU property can justify a $200-million theatrical release, a strategic narrowing that could define the studio's next phase.
- For Indian exhibitors and distributors, the pivot to fewer, bigger franchise bets could mean more reliable tentpole weekends but fewer overall MCU releases competing for screens.
Frequently Asked Questions
Which Marvel movies are confirmed as top priorities after Avengers: Secret Wars?
According to The Times of India and industry insider reports, Marvel Studios is prioritising Spider-Man 5, Black Panther 3, Shang-Chi 2, an X-Men project, and a Thunderbolts sequel as its next wave of development projects.
Why has Doctor Strange 3 been deprioritised by Marvel?
While no official reason has been given, insider reports suggest Doctor Strange 3 is currently on the backburner. Industry speculation, as reported across trade circles, points to Marvel focusing resources on franchises with stronger global box-office track records rather than continuing to expand every corner of the multiverse.
How does Marvel's priority list affect Indian audiences?
The list heavily favours franchises that have proven theatrical draw in India — particularly Spider-Man, which crossed ₹218 crore in Hindi with No Way Home. For Indian multiplex audiences, this likely means fewer mid-tier MCU releases competing for screens and more concentrated tentpole events designed to open big.
Is Shang-Chi 2 still happening?
Yes. According to The Times of India's report and multiple insider accounts, Shang-Chi 2 remains among Marvel's top-priority projects, suggesting the studio views the franchise as having significant growth potential, particularly in Asian markets.
click and follow Indiaherald WhatsApp channel